Jeff Yass’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-155,800
Closed -$3.32M 13519
2024
Q1
$3.32M Buy
+155,800
New +$1.86M ﹤0.01% 4318

Jeff Yass's FUSN Position: Q2 2024 in Review

Jeff Yass sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 147,547 shares — an estimated $3.15M sold.

Jeff Yass first reported a position in FUSN in Q1 2021 and held it in 3 quarters. The position peaked at $3.15M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Jeff Yass reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Jeff Yass sold 147,547 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.15M.
  • Jeff Yass first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2021 and held it in 3 quarters.
  • Jeff Yass's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.15M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.